KURA
Kura Oncology Inc

3,388
Mkt Cap
$857.99M
Volume
1.57M
52W High
$19.73
52W Low
$5.41
PE Ratio
-3.98
KURA Fundamentals
Price
$9.86
Prev Close
$10.16
Open
$10.02
50D MA
$9.20
Beta
0.99
Avg. Volume
1.91M
EPS (Annual)
-$2.02
P/B
3.54
Rev/Employee
$280,640.63
Loading...
Loading...
News
all
press releases
Kura Oncology FY2025 EPS Forecast Cut by Cantor Fitzgerald
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Research analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for Kura Oncology in a research note issued to investors on Wednesday...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
Kura Oncology FY2025 EPS Forecast Reduced by Leerink Partnrs
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Analysts at Leerink Partnrs decreased their FY2025 earnings per share estimates for Kura Oncology in a research report issued on Tuesday, November...
MarketBeat·19h ago
News Placeholder
FY2025 Earnings Forecast for Kura Oncology Issued By Wedbush
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Investment analysts at Wedbush boosted their FY2025 earnings estimates for shares of Kura Oncology in a report issued on Tuesday, November 4th...
MarketBeat·19h ago
News Placeholder
Brokers Offer Predictions for Kura Oncology FY2025 Earnings
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities researchers at Brookline Capital Management cut their FY2025 earnings per share estimates for shares of Kura Oncology in a report released...
MarketBeat·2d ago
News Placeholder
Kura Oncology FY2025 EPS Estimate Boosted by HC Wainwright
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - HC Wainwright lifted their FY2025 earnings estimates for Kura Oncology in a note issued to investors on Tuesday, November 4th. HC Wainwright analyst...
MarketBeat·2d ago
News Placeholder
Brokers Offer Predictions for Kura Oncology FY2027 Earnings
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities researchers at Brookline Capital Management reduced their FY2027 earnings per share (EPS) estimates for shares of Kura Oncology in a...
MarketBeat·3d ago
News Placeholder
Kura Oncology (KURA) Reports Q3 Loss, Lags Revenue Estimates
Kura Oncology (KURA) delivered earnings and revenue surprises of -49.12% and -75.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
KURA Stock Rises Pre-Market After Receiving Milestone Payment Related To Cancer Drug Development Agreement
Stocktwits·16d ago
News Placeholder
Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates
Kura Oncology (KURA) delivered earnings and revenue surprises of -600.00% and -89.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Is the Options Market Predicting a Spike in Kura Oncology Stock?
Zacks·5mo ago

Latest KURA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.